Paralysis of skeletal muscle by butanedione monoxime, a chemical phosphatase

Pflugers Arch. 1988 Jan;411(1):76-9. doi: 10.1007/BF00581649.

Abstract

The chemical phosphatase butanedione monoxime (BDM) reversibly inhibited twitches and tetanic contractions in bundles of rat soleus fibres in a dose-dependent manner (2-20 mM) but had no effect on the amplitude or time course of action potentials. In addition, BDM reversibly reduced the amplitude of potassium contractures demonstrating a depressant effect on contraction not mediated by action potentials. BDM had no effect on asymmetric charge movement but depressed calcium currents across the surface membrane in voltage-clamped fibres. The most significant effect of BDM on excitation-contraction coupling was a reduction in the amplitude of the calcium transient associated with contraction in aequorin-injected fibres. While these experiments do not eliminate the possibility of a direct effect of BDM on contractile filaments, reduction of calcium release from the sarcoplasmic reticulum, at least at low concentrations of BDM (below 2 mM), would seem to be the main mechanism for the inhibition of contractions in rat skeletal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aequorin
  • Animals
  • Butanones / pharmacology*
  • Calcium / pharmacology
  • Calcium / physiology
  • Diacetyl / analogs & derivatives
  • Diacetyl / pharmacology*
  • Electrophysiology
  • Membrane Potentials / drug effects
  • Muscle Contraction / drug effects
  • Muscles / drug effects*
  • Muscles / physiopathology
  • Paralysis / chemically induced*
  • Phosphoric Monoester Hydrolases / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Sarcoplasmic Reticulum / drug effects

Substances

  • Butanones
  • diacetylmonoxime
  • Aequorin
  • Phosphoric Monoester Hydrolases
  • Diacetyl
  • Calcium